Institute of Public and Preventive Health
“Public health is what we, as a society, do collectively to assure conditions for people to be healthy.”
-Institute of Medicine (IOM) Future of Public Health, 1988
As the state of Georgia's only public academic health center, Georgia Regents University has unique strengths and responsibilities in developing clinical services and biomedical research responsive to community health needs. The innovative solutions developed through the Institute of Public and Preventive Health will ensure that Georgia will be a healthy place to live and work for generations.
An External Advisory Board of community stakeholders will support and counsel the institute to ensure quality and relevance of the institute's research and service.
Living in Georgia should not be an indicator for susceptibility to dangerous, infectious diseases and other lagging health factors, but it is. Many preventable factors leave Georgians susceptible to disease. The Institute of Public and Preventive Health continues to find real-world solutions and uncover resource-preserving, preventive measures.
Currently, Georgia ranks among the worst for teen pregnancy, low birth-weight babies, pre-term births, and infant mortality. For many, these are shocking facts. For others, they are simply the reality of living here.
Through the Georgia Prevention Center, GRU has already formed strong alliances with schools, parents, outreach organizations and other segments of the community to research, develop, and implement innovative solutions for children's health issues. We've taken important steps to address the earliest roots of childhood obesity and with your help we can do even more.
- Dr. Christopher W. Cutler has been named Associate Dean for Research at the Georgia Regents University College of Dental Medicine.
- Here are 10 resolutions that Children’s Hospital of Georgia physicians encourage you to commit to in 2015 in order to maintain a healthier lifestyle.
- Electronic medication monitoring caps may help physicians put together the puzzle of why children taking a medicine that promises to curb sickle cell disease are showing mixed, confusing results.